Biodefense
Programmable Biology Puts Biotech on the Geopolitical Agenda
Synthetic biology is driving a manufacturing revolution, and policymakers are taking note.
Latest in supply chain
Synthetic biology is driving a manufacturing revolution, and policymakers are taking note.
America’s drug industry is poised to face the same manufacturing crisis the semiconductor industry faces today: a supply chain mired with chokepoints in East Asia that pose direct risks to U.S. national security and economic growth.
To make progress on supply chain security, the U.S. government will need to clarify its goals; create a cohesive, forward-thinking strategy; and offer alternatives to a cold divestment of Chinese ICT products.
On Feb. 24, President Biden signed an executive order titled “America’s Supply Chains,” outlining a process for the United States to identify and mitigate the risks and challenges it faces in a series of critical supply chains, including that of information and communications technology (ICT).
An old trade statute could help the U.S. foreclose inadvertent domestic demand for goods made with forced labor. But the statute must be revised to accomplish that goal.
As nations become increasingly interested in defending against supply chain attacks, it is necessary to establish trust in digital systems. Here, we evaluate the strengths and limitations of various trust-building proposals.
There are a lot of Chinese component suppliers in the U.S. energy grid. What’s the supply-chain security risk?
A recent executive order on the bulk electric power system signals that still-in-progress efforts to ban Chinese-made telecommunications equipment from U.S. networks may represent a new approach to critical infrastructure security more broadly.
Lawfare's biweekly roundup of U.S.-China technology policy news.
The Committee on Foreign Investment in the United States (CFIUS) protects U.S. national security by regulating against attempts by foreign commercial efforts to obtain control in a U.S. trade or business.